Health ❯Pharmaceuticals

Drug Pricing

Drug Pricing Pharmaceuticals Drug Pricing Investment Forecasting U.S.-China Relations Market Trends Healthcare Access Drug Manufacturing Vaccines

Trump Administration Begins Enforcing Prescription Drug Price Controls

HHS and CMS initiate implementation of most-favored-nation pricing order as questions about legal authority and innovation impacts persist.

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

Trump Administration’s Planned 25% Tariffs on Pharmaceuticals Expected to Raise U.S. Drug Costs by $51 Billion Annually

Trump Administration Weighs Pilot to Tie U.S. Drug Prices to Global Benchmarks

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline